News and Updates

CMS Releases Proposed Physician Fee Schedule Rule

On July 13, 2021, the Centers for Medicare & Medicaid Services (CMS) released its proposed physician fee schedule rule for calendar year 2022, which includes provisions extending and expanding certain telehealth flexibilities, delaying the penalty phase of the...

read more

SCOTUS Upholds Affordable Care Act in 7-2 Ruling

On June 17, 2021, the Supreme Court issued its long-anticipated decision in California v. Texas, upholding the Affordable Care Act once again in a 7-2 ruling. The Court did not reach the merits of whether the now $0 individual mandate penalty rendered the law...

read more

Manufacturers Respond to HRSA 340B Cease and Desist Letter

On June 10, 2021, Eli Lilly became the third manufacturer to response to HRSA’s May 17th Cease and Desist letter on 340B drug pricing. The response details Eli Lilly’s rejection of HRSA’s reasoning in its Cease and Desist letter, arguing that the agency’s reasoning is...

read more

Judge Enjoins 340B ADR Rule, But Only as Applied to Eli Lilly

A district court judge in Indiana today issued a narrow ruling enjoining the Department of Health and Human Services (HHS) from implementing a rule issued in December finalizing administrative dispute resolution (ADR) procedures for the 340B program. Eli Lilly argued...

read more

District Judge in California Dismisses Hospital 340B Lawsuit

A district court judge in California today dismissed a lawsuit filed by several hospital associations seeking to ensure enforcement of 340B discounts when drugs are dispensed through contract pharmacies. The judge concluded that the lawsuit was premature, as no final...

read more

CMS Approves 10-year Renewal of Texas 1115 Waiver

On January 15, 2021, CMS approved a 10-year renewal of Texas’ Section 1115 Medicaid waiver using emergency authority to bypass notice and comment requirements. The renewed waiver will extend and expand the state’s Uncompensated Care Pool and envisions the adoption of...

read more